The present invention relates to a class of compounds represented by the Formula I ##STR1## or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the .alpha..sub.v .beta..sub.3 integrin.
Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid compounds
申请人:G. D. Searle & Co.
公开号:US06028223A1
公开(公告)日:2000-02-22
The present invention relates to a class of compounds represented by the Formula I ##STR1## or a pharmaceutically acceptable salt thereof, wherein A is ##STR2## pharmaceutical compositions thereof and methods of using such compounds and compositions as .alpha..sub.v .beta..sub.3 antagonists.
Para- substituted phenylene derivatives and their use as integrin antagonists
申请人:G.D. SEARLE & CO.
公开号:EP1157985A1
公开(公告)日:2001-11-28
The present invention relates to a class of compounds represented by Formula I
or a pharmaceutically acceptable salt thereof, pharmaceutical composition comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the αvβ3 integrin.
本发明涉及一类由式 I
或其药学上可接受的盐、包含式 I 化合物的药物组合物,以及选择性抑制或拮抗 αvβ3 整合素的方法。
CYCLOPROPYL ALKANOIC ACID DERIVATIVES
申请人:G.D. SEARLE & CO.
公开号:EP0889875B1
公开(公告)日:2001-06-20
PARA-SUBSTITUTED PHENYLPROPANOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS